CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 13 filers reported holding CYCLO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $514 | -10.8% | 362 | 0.0% | 0.00% | – |
| Q2 2023 | $576 | +89.5% | 362 | 0.0% | 0.00% | – |
| Q1 2023 | $304 | -40.9% | 362 | 0.0% | 0.00% | – |
| Q4 2022 | $514 | -48.6% | 362 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 362 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -98.3% | 362 | -98.0% | 0.00% | – |
| Q1 2022 | $58,000 | +13.7% | 18,203 | +31.4% | 0.00% | – |
| Q4 2021 | $51,000 | -42.0% | 13,851 | +5.5% | 0.00% | – |
| Q3 2021 | $88,000 | -20.7% | 13,134 | +21.1% | 0.00% | – |
| Q2 2021 | $111,000 | – | 10,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 75,787 | $240,000 | 0.00% |
| ROYAL BANK OF CANADA | 746 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 255,065 | $808,000 | 0.00% |
| UBS Group AG | 2,291 | $7,000 | 0.00% |
| IFP Advisors, Inc | 26 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,047 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,316 | $153,000 | 0.00% |
| STATE STREET CORP | 28,300 | $90,000 | 0.00% |
| CITIGROUP INC | 1,232 | $4,000 | 0.00% |